DELFIA™ Xpress random access platform for prenatal screening. Confidence in your results, total flexibility of a random access system, supports 1st and 2nd trimester aneuplody screening strategies being implemented in today' screening programs. The instrument is also optimized for pre-eclampsia screening and management in all trimesters.
Loading...
The DELFIA Xpress has been developed to streamline workflows in laboratories and clinics providing prenatal screening services. The platform offers a variety of benefits critical for operational efficiency, with a wide range of available kits for all trimesters, it supports different strategies in aneuploidy and pre-eclampsia screening programs.
Efficient workflows for aneuploidy and pre-eclampsia screening in clinics and labs.
Barcoded reagents and tubes deliver accuracy and minimize human error.
DELFIA assays deliver reliable results backed by decades of clinical excellence.
Bench-top design with 85×55 cm footprint delivers high performance in limited space.
| Aneuploidy screening | Neural tube defect screening | Pre-eclampsia screening and management | |
|---|---|---|---|
| 1st Trimester |
|
|
|
| 2nd Trimester |
|
|
|
| 3rd Trimester |
|
The DELFIA Xpress streamlines prenatal screening operations for laboratories and clinics, delivering crucial workflow efficiency benefits. With an extensive kit portfolio covering all trimesters, the platform enables flexible implementation of various aneuploidy and pre-eclampsia screening strategies. The system combines random-access speed and adaptability with the intuitive operation of next-generation instrument design and contemporary software architecture. Barcode-driven security ensures accurate reagent and sample tracking, while the reliability of proven DELFIA chemistry provides confidence in every result. Integrated LifeCycle prenatal screening software completes the solution, making it an optimal platform for delivering OSCAR (one stop clinic for assessment of risk) programs.
| Sample dilution | As pre-assay stage, automatically within instrument |
|---|---|
| Kit capacity | 96 tests or 72 tests (PlGF & sFlt-1 48 tests) |
| Bulk reagents capacity | 180-250 tests |
Revvity does not endorse or make recommendations with respect to research, medication, or treatments. All information presented is for informational purposes only and is not intended as medical advice. For country specific recommendations please consult your local health care professionals.
| Dimensions | 85.0 cm (W) x 55.0 cm (D) x 66.0 cm (H) |
|---|---|
| Weight |
65.0 kg
|
| Application |
Prenatal screening
Pre-eclampsia
|
|---|---|
| Brand |
DELFIA™ Xpress
|
| Detection Modality |
DELFIA
|
| Disorders |
Down Syndrome
Pre-Eclampsia
|
| Hands on Time |
30 minutes per test
|
| Power Rating |
100/240 +/- 10% V, 50/60 Hz
|
| Regulatory Status |
CE-IVD marked
|
| Research Areas |
Maternal & Fetal Health
|
| Sample Volume |
10 or 15 μL per test (or 40 μL per test for PlGF)
|
| Throughput |
40 tests per hour
|
Are you looking for resources, click on the resource type to explore further.
Brochure for DELFIA prenatal screening solutions and assays including traditional biochemical screening, pre-eclampsia
Brochure on pre-eclampsia management in the 2nd and 3rd trimester of pregnancy with PlGF or sFlT-1/PlGF ratio. Includes also...
Brochure for pre-eclampsia screening with the PlGF 1-2-3 kit in the 1st trimester of pregnancy.
This brochure is about advanced pre-eclampsia risk assessment using PlGF testing, automated analysis, and integrated prenatal...
Brochure for Revvity's complete portfolio for prenatal screening solutions including traditional biochemical screening, pre...
Loading...
We are here to answer your questions.